Description
An antagonist/partial agonist of the androgen receptor (IC50 = 26 nM in humans) that has been shown to have clinical use in androgen-dependent conditions such as prostate cancer, hirsutism, and alopecia; suppresses accessory sexual glands and fertility in adult male rats (10 mg/animal/day); induces apoptosis of hepatocytes in rats at 0.3 µM after 72 hours exposure
Formal name: (1β,2β)-17-acetyloxy-6-chloro-1,2-dihydro-3’H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione
Synonyms: Androcur®|CPA|Cyprostat|NSC 81430|SH 714
Molecular weight: 416.9
CAS: 427-51-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cancer||Research Area|Cell Biology|Cell Death|Apoptosis||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Androgens||Research Area|Endocrinology & Metabolism|Reproductive Biology